We did not receive public comments on this proposal, and therefore, we are finalizing the submission deadlines for eCQM data as proposed
And if youre curious how CJC-1295 stacks against other peptides (like the targeted fat-burner AOD-9604 mentioned earlier)
Last year, FDAacting through the Office of Prescription Drug Promotion (OPDP) within the Center for Drug Evaluation and Research (CDER)issued a high volume of untitled and warning letters as part of a broader push against directtoconsumer (DTC) drug advertising, including 58 letters addressing claims about compounded GLP1s (e.g., semaglutide and tirzepatide) and other compounded products (e.g., sildenafil and tadalafil).[2] By mid2026, activity appeared to taper offraising the question whether FDA had shifted priorities, for example due to personnel changes, or simply paused the effort
KOHJIN Life Sciences Co
You may need to restart titration from a lower dose to avoid GI side effects when re-introducing the drug
Providers create personalized weight loss plans tailored to each patient's medical history, lab results, and lifestyle goals, with unlimited messaging to adjust care plans as needed
